Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?

References

• File TM Jr., Marrie TJ. Burden of community acquired pneumonia in North American adults. Postgrad Med 2010; 122:130-4; http://dx.doi.org/10.3810/pgm.2010.03.2130
   PubMed Web of Science ®Google Scholar
• Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007; 82:93-104; PMID:17380597
   PubMedGoogle Scholar
• Prato R, Tafuri S, Fortunato F, Martinelli D. Why it is still important that countries know the burden of pneumococcal disease. Hum Vaccin 2010; 6:91821; http://dx.doi.org/10.4161/hv.6.11.13352
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction–eight states, 1998–2005. MMWR Morb Mortal Wkly Rep 2008; 57:144-8; PMID:18272956
   PubMedGoogle Scholar
• Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 2012; 12:207; PMID:22954038; http://dx.doi.org/10.1186/1471-2334-12-207
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep 2010; 59:253-7; PMID:20224541
   PubMedGoogle Scholar
• Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R. Changes in molecular epidemiology of streptococcus pneumonia causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microbiol 2013; 51:8207; http://dx.doi.org/10.1128/JCM.01917-12
   Web of Science ®Google Scholar
• Alfonsi V, D'Ancona F, Giambi C, Nacca G, Rota MC. Regional coordinators for infectious diseases and vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy 2011; 103:176-83; PMID:22030308; http://dx.doi.org/10.1016/j.healthpol.2011.10.002
   PubMed Web of Science ®Google Scholar
• Ministero della Salute. Italia. Indicazioni in merito alla somministrazione del vaccino antipneumococcico Prevenar 13 in età pediatrica. Circolare del 27 Maggio 2010. prot.n. 111432/72AF del 03/06/2010. [Italian] Available from: http://www.fimpcalabria.org/public/vaccinazioni/indicazioni%20in%20merito%20alla%20somministrazione%20del%20vaccino%20antipneumococcico%20prevear%2013%20in%20et%C3%A0%20pediatrica%20%282%29.pdf. Accessed 19 November 2015.
   Google Scholar
• Ministero della Salute. Piano Nazionale Prevenzione Vaccinale (PNPV) 2012–14. Gazzetta Ufficiale n. 60 del 12.03.2012 (Supplemento Ordinario n.47). [Italian]. Available from: http://www.salute.gov.it/imgs/c_17_pubblicazioni_1721_allegato.pdf
   Google Scholar
• WHO Publication. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine 2012; 30:4717-8; PMID:22621828; http://dx.doi.org/10.1016/j.vaccine.2012.04.093
   PubMed Web of Science ®Google Scholar
• Tuscany Region. Regional immunization schedule. [Italian] Available from: http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id = 5099142&nomeFile = Delibera_n.571_del_27-04-2015-Allegato-1
   Google Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67:71-9; PMID:20729232; http://dx.doi.org/10.1136/thx.2009.129502
   PubMed Web of Science ®Google Scholar
• Martinelli D, Pedalino B, Cappelli MG, Caputi G, Sallustio A, Fortunato F, Tafuri S, Cozza V, Germinario C, Chironna M, et al. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010–2013. Hum Vaccin Immunother 2014; 10(1):33-9; PMID:24096297; http://dx.doi.org/10.4161/hv.26650
   PubMed Web of Science ®Google Scholar
• Bechini A, Taddei C, Barchielli A, Levi M, Tiscione E, Santini MG, Niccolini F, Mechi MT, Panatto D, Amicizia D, et al. A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010–2012. Hum Vaccin Immunother 2015; 11(1):156-65; PMID:25483529; http://dx.doi.org/10.4161/hv.34418
   PubMed Web of Science ®Google Scholar
• Fortunato F, Martinelli D, Cappelli MG, Cozza V, Prato R. Impact of pneumococcal conjugate universal routine vaccination on pneumococcal disease in Italian children. J Immunol Res 2015; 2015:206757; PMID:26351644; http://dx.doi.org/10.1155/2015/206757
   PubMed Web of Science ®Google Scholar
• Amodio E, Costantino C, Boccalini S, Tramuto F, Maida CM, Vitale F. Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies. Hum Vaccin Immunother 2014; 10(5):1337-42; PMID:24577505; http://dx.doi.org/10.4161/hv.27947
   PubMed Web of Science ®Google Scholar
• Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect 2013; 19(Suppl 1):1-9; PMID:24083785; http://dx.doi.org/10.1111/1469-0691.12320
   PubMed Web of Science ®Google Scholar
• Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, et al. Collaborative Group for Pneumococcal Vaccination in Liguria. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine 2009; 27:3459-62; PMID:19200823; http://dx.doi.org/10.1016/j.vaccine.2009.01.052
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugatevaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011 Oct; 11(10):760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 2015 May; 15(5):535-43; PMID:25801458; http://dx.doi.org/10.1016/S1473-3099(15)70044-7
   PubMed Web of Science ®Google Scholar
• Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C. Italian group for the study of bacterial nasopharyngeal carriage in children. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine 2014; 32:1375-81; PMID:24486364; http://dx.doi.org/10.1016/j.vaccine.2014.01.023
   PubMed Web of Science ®Google Scholar
• Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indolfi G, Mattei R, Zuliani M, Adriani B, Degl'Innocenti R, Consales G, et al. Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination? Hum Vaccin Immunother 2016; 12(2):344-50.
   PubMed Web of Science ®Google Scholar
• Zhou F, Kyaw MH, Shefer A, Winston CA, Nuorti JP. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med 2007; 161:1162-8; PMID:18056561; http://dx.doi.org/10.1001/archpedi.161.12.1162
   PubMed Web of Science ®Google Scholar